Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Hirsutism is excessive male-pattern hair growth mainly caused by ovarian hormones, and severe cases may require costly treatment with side effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

A rare, non-cancerous ovarian tumor was successfully treated with surgery, improving the patient's symptoms.

Thyroid receptor β can help develop new drugs to treat hair loss.

The treatment was ineffective in humans.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Elagolix did not effectively treat polycystic ovary syndrome.

Topical finasteride may help treat facial hirsutism in women.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

THSG from a Chinese plant helps with aging and related diseases.

A new genetic mutation causes severe Leydig cell hypoplasia, affecting sexual development.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

AH-001 could be a safer and more effective treatment for hair loss.

Blocking the Hedgehog pathway may help overcome drug resistance in multiple myeloma.

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Sebocytes play a key role in controlling androgen levels in human skin.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Androstanediol glucuronide is a reliable marker for hirsutism in women.